Search Result "DOTA-TATE"
Overview of Development and Formulation of 177Lu-DOTA-TATE for PRRT
Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 1 Year: 2016 Page: 8-18
Author(s): Wouter A.P. Breeman,Ho Sze Chan,Rory M.S. de Zanger,Mark K. Konijnenberg,Erik de Blois
Preparation of Therapeutic Dose of 177Lu-DOTA-TATE Using a Novel Single Vial Freeze-dried Kit: A Comparison with âIn-situâ Preparation at Hospital Radiopharmacy
Journal: Current Radiopharmaceuticals
Volume: 7 Issue: 1 Year: 2014 Page: 12-19
Author(s): Tapas Das,Sharmila Banerjee,Ajit Shinto,K.K. Kamaleshwaran,H.D. Sarma
[177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma
Journal: Current Radiopharmaceuticals
Volume: 3 Issue: 1 Year: 2010 Page: 29-36
Author(s): Ganesan Vaidyanathan, Donna J. Affleck, Xiao-Guang Zhao, Stephen T. Keir, Michael R. Zalutsky
Alternative method to determine Specific Activity of 177Lu by HPLC
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 2 Year: 2015 Page: 119-122
Author(s): Wouter A. P. Breeman,Rory M. S. de Zanger,Ho Sze Chan,Erik de Blois
177Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay
Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 1 Year: 2016 Page: 85-93
Author(s): Henia Balter,Trindade Victoria,Terán Mariella,Gaudiano Javier,Ferrando Rodolfo,Paolino Andrea,Rodriguez Graciela,Hermida Juan,De Marco Eugenia,Oliver Patricia
Toxicity and Tolerability of 177Lu-DOTA-TATE PRRT with a Modified AdministeredActivity Protocol in NETs of Variable Origin â A Phase 2 RegistryStudy
Journal: Current Radiopharmaceuticals
Volume: 15 Issue: 2 Year: 2022 Page: 123-133
Author(s): Alireza Khatami,Golmehr Sistani,Duncan E. K. Sutherland,Sarah DeBrabandere,Robert H. Reid,David T. Laidley
Neuroendocrine Tumours with Secondary Liver Lesions
Ebook: Functional Molecular Imaging In Hepatology
Volume: 1 Year: 2012
Author(s): Valentina Ambrosini,Davide Campana,Paola Tommassetti,Stefano Fanti
Doi: 10.2174/978160805290511201010120
Theranostic Applications of Lutetium-177 in Radionuclide Therapy
Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 1 Year: 2016 Page: 94-101
Author(s): Tapas Das,Sharmila Banerjee
Peptide-based Radiopharmaceuticals for Targeted Tumor Therapy
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 1 Year: 2014 Page: 139-152
Author(s): C. Dong, Z. Liu, F. Wang
A New Buffer for Gallium-68 Labeling Suitable for use in Nuclear Medicine;Triethanolamine (TEA)
Journal: Current Radiopharmaceuticals
Volume: 16 Issue: 4 Year: 2023 Page: 308-314
Author(s):